Active, not recruitingNot applicableNCT03130777
ALTERRA: SAPIEN 3 THV With the Alterra Adaptive Prestent
Studying Tetralogy of Fallot
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Edwards Lifesciences
- Principal Investigator
- Evan Zahn, MD, FACC, FSCAI, PharmDCedars-Sinai Heart Institute
- Intervention
- Edwards Alterra Adaptive Prestent with SAPIEN 3 THV(device)
- Enrollment
- 86 enrolled
- Eligibility
- All sexes
- Timeline
- 2017 – 2032
Study locations (14)
- Cedars-Sinai Medical Center, Los Angeles, California, United States
- University of California, Los Angeles, Los Angeles, California, United States
- University of California, San Francisco, San Francisco, California, United States
- Children's Hospital Colorado, Aurora, Colorado, United States
- Emory University/ Children's Healthcare of Atlanta (CHOA), Atlanta, Georgia, United States
- St. Louis Children's Hospital, St Louis, Missouri, United States
- Columbia University Medical Center, New York, New York, United States
- Cincinnati Children's Hospital, Cincinnati, Ohio, United States
- Nationwide Children's Hospital, Columbus, Ohio, United States
- Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States
- Children's Health Dallas, Dallas, Texas, United States
- Texas Children's Hospital, Houston, Texas, United States
- University of Virgina, Charlottesville, Virginia, United States
- Seattle Children's Hospital, Seattle, Washington, United States
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT03130777 on ClinicalTrials.govOther trials for Tetralogy of Fallot
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE4NCT06668389Sodium-Glucose Cotransporter 2 Inhibitors for Repaired Tetralogy of Fallot Patients for Enhancement of Cardio-Pulmonary Status TrialThe University of Hong Kong
- RECRUITINGNANCT06822400Investigation of Tetralogy of Fallot in NeonatesBeijing Anzhen Hospital
- ACTIVE NOT RECRUITINGNCT06282926Role of 3D Echocardiography Knowledge-based Reconstruction in ACHDGuy's and St Thomas' NHS Foundation Trust
- RECRUITINGPHASE1NCT04713657Beta-blocker Administration for Cardiomyocyte DivisionWeill Medical College of Cornell University
- ACTIVE NOT RECRUITINGNCT05378386ALTERRA Post-Approval StudyEdwards Lifesciences
- RECRUITINGNCT05122962Pathophysiologic Mechanism for Arrhythmias and Impaired Aerobic Capacity in Tetralogy of Fallot and Other Congenital Heart DiseasesMayo Clinic
- RECRUITINGNCT05288894Repaired Tetralogy of Fallot Italian RegistryAzienda Ospedaliero, Universitaria Ospedali Riuniti
- ACTIVE NOT RECRUITINGNANCT03983512PULSTA Transcatheter Pulmonary Valve Pre-Approval StudyTaewoong Medical Co., Ltd.